Physician profile
Jay Alan Redan
NPI 1376562553
$134,054.97
in general payments reported to CMS, 2019-2025
30 companies · $2,069 in 2025
The $2,069 reported for 2025 was more than what 82% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $21K · 2021: $27K · 2022: $39K · 2023: $9,589 · 2024: $14K · 2025: $2,069.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,100 · Honoraria: $2,250 · Food and Beverage: $2,024 · Travel and Lodging: $897.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,635.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,100.00 |
| Honoraria | $2,250.00 |
| Food and Beverage | $2,023.74 |
| Travel and Lodging | $896.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $44,075.23 | 2019-2024 | Zynrelef |
| Medical Device Business Services, INC. | $32,013.41 | 2020-2025 | |
| Arthrex, INC. | $26,394.94 | 2019-2024 | Arthrex |
| Ethicon INC. | $7,077.69 | 2019-2024 | Echelon Circular, Echelon Endopath, Echelon Flex |
| Covidien LP | $6,609.85 | 2019 | |
| Richard Wolf Medical Instruments Corp. | $3,917.54 | 2019 | |
| Baudax Bio INC. | $3,705.00 | 2020-2021 | |
| Davol INC. | $2,303.03 | 2023-2025 | Phasix Mesh |
| Allergan, INC. | $2,018.38 | 2021 | |
| Ethicon US, LLC | $1,310.50 | 2021-2025 | Echelon Circular, Harmonic, Echelon Flex |
| Medtronic, INC. | $1,068.81 | 2021-2024 | Interstim |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $600.00 | 2025 | |
| Kci USA, INC. | $491.39 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $371.75 | 2019-2025 | |
| Stryker Corporation | $311.82 | 2019 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Enterra Medical, INC. | $246.77 | 2024-2025 | |
| Atricure, INC. | $229.92 | 2021-2025 | Atricure Cryoice Cryosphere Cryoablation System, Atricure Cryoice Cryoablation System (Cryo2) |
| Merit Medical Systems INC | $176.25 | 2021 | |
| Baxter Healthcare | $169.97 | 2019 | |
| Abbvie INC. | $164.82 | 2021-2024 | |
| Tela Bio, INC. | $134.99 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $131.86 | 2019-2024 | Exparel |
| W. L. Gore & Associates, INC. | $115.14 | 2022 | |
| Smith+Nephew, INC. | $103.99 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $100.00 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $58.23 | 2024-2025 | Imfinzi |
| Karl Storz Endoscopy-America | $51.09 | 2020 | |
| Reprise Biomedical, INC. | $43.55 | 2021 | |
| Ambu INC. | $31.55 | 2025 | |
| Abiomed | $27.50 | 2024 | Impella |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Redan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.